Oura has launched AI-powered glucose tracking and meal logging features aimed at enhancing metabolic health monitoring for its users.

These innovative features are available on both iOS and Android platforms for U.S. members, with the accompanying Stelo biosensor priced at $99.

With rising global rates of obesity and prediabetes, the need for effective health management tools like Oura's glucose tracking has become increasingly critical.

Oura's smart ring has gained significant traction, achieving nearly $500 million in sales in 2024, with 2.5 million rings sold worldwide.

These new capabilities expand Oura's functionality beyond sleep and activity tracking, positioning it as a comprehensive wellness tool in a competitive market.

The timing of this metabolic tracking launch raises questions, especially as Oura has recently taken legal action against Ultrahuman for allegedly copying its smart ring design.

Oura recently celebrated a legal victory in a patent infringement case against Ultrahuman and RingConn, validating the strength of its patents.

Oura's extensive biometric tracking capabilities and partnerships with over 800 organizations underscore its commitment to leading health technology innovation.

The company emphasizes that its new features do not replace professional medical advice, urging users to consult physicians for health decisions.

While the app provides valuable insights, it currently lacks certain functionalities, such as accessing meal timing graphics without logging a meal.

This partnership with Dexcom signifies a convergence of consumer health and medical devices, showcasing a new business model in the health tech sector.

The app provides users with non-judgmental feedback to help improve their dietary choices, focusing on personalized insights.